Latest Clinical Trials
During the early stages of most clinical trials, medical researchers tend to recruit healthy adult males with no comorbidities. This is because they generally represent the safest segment of the population for experimental therapies to be tested on. In contrast, women of reproductive age tend to be the last segment of the population to be…
There are various options for physicians to diagnose MTC, from physical examination to an ultrasound scan to molecular imaging.
Previous to its widespread use as a cancer biomarker, including its role in raising suspicion of medullary thyroid cancer (MTC), calcitonin had an interesting history. In the Journal of Musculoskeletal Neuronal Interactions, Srinivasan and colleagues detailed the early history of calcitonin. It was first discovered as a blood-calcium lowering hormone in 1961. It has been…
I am grateful that medullary thyroid cancer (MTC) does not include typical chemotherapy options like other cancers.
For HCPs, I think it might be helpful to point out both the dos and the don’ts from the perspective of someone living with medullary thyroid carcinoma (MTC).
I deal with the persistent side effects of medullary thyroid cancer (MTC) as well as the treatments I received for it.
The Alliance for Regenerative Medicine aims to help in the development of safe and effective regenerative therapies that can benefit rare disease patients.
Ultragenyx CEO Dr. Emil D. Kakkis said federal regulators should focus more on biomarkers and less on clinical endpoints when it comes to drug approvals.
Dr. Haggi Mazeh, chief of surgery at one of Israel’s top hospitals, discusses diagnosing and treating medullary thyroid carcinoma.
MTC “can get aggressive and nasty” but it is not necessarily a death sentence, said surgical oncologist David Goldenberg, MD, FACS, author of a new book.
Rare Care Podcast
Endocrine Surgeon Dr. Haggi Mazeh Describes the Challenges of Treating MTC